Addus HomeCare (ADUS) insider sells 1,083 shares under 10b5-1 plan

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Addus HomeCare Corp executive David W. Tucker reported selling company stock in two open-market transactions. As EVP and Chief Strategy Officer, he sold 704 shares of common stock on February 24 at $107.35 per share and 379 shares on February 25 at $105.36 per share.

These sales, totaling 1,083 shares, were made pursuant to a previously established Rule 10b5-1 trading plan to satisfy tax obligations arising from the vesting of restricted stock awards granted by Addus. Following the most recent sale, Tucker directly holds 10,423 shares of Addus common stock.

Insider Trade Summary

Net Seller: 1,083 shares ($115,506)

Net Sell 2 txns

Insider TUCKER DAVID W.

Role EVP, Chief Strategy Officer

Sold 1,083 shs ($116K)

Type	Security	Shares	Price	Value
Sale	Common Stock	379	$105.36	$40K
Sale	Common Stock	704	$107.35	$76K

Holdings After Transaction: Common Stock — 10,423 shares (Direct)

Footnotes (1)

This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer. Adoption date of referenced 10b5-1(c) plan is: 03/13/2025

Form 4 Insider Transactions: What Each Field Means →

02/26/2026 - 04:32 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TUCKER DAVID W.

(Last)

(First)

(Middle)

6303 COWBOYS WAY

SUITE 600

(Street)

FRISCO

75034

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, Chief Strategy Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/24/2026		S⁽¹⁾⁽²⁾		704	D	$107.35	10,802	D
Common Stock	02/25/2026		S⁽¹⁾⁽²⁾		379	D	$105.36	10,423	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer.

2. Adoption date of referenced 10b5-1(c) plan is: 03/13/2025

	/s/ Brian Poff, Attorney-in-Fact for David W. Tucker	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Addus HomeCare (ADUS) executive David W. Tucker report?

David W. Tucker reported selling shares of Addus HomeCare common stock in two open-market transactions. The sales were disclosed on a Form 4 and relate to stock previously granted to him as restricted stock awards by the company.

How many Addus HomeCare (ADUS) shares did David W. Tucker sell and at what prices?

He sold 704 shares of Addus common stock at $107.35 per share on February 24 and 379 shares at $105.36 per share on February 25. Together, these two open-market sales totaled 1,083 shares of Addus stock.

Why did David W. Tucker sell Addus HomeCare (ADUS) shares according to the Form 4?

The Form 4 states the sales were made under a previously established Rule 10b5-1 trading plan to satisfy tax obligations. Those tax obligations arose when restricted stock awards granted by Addus vested, triggering associated tax liabilities for the executive.

What is a Rule 10b5-1 trading plan in the context of Addus (ADUS) insider sales?

A Rule 10b5-1 trading plan is a pre-arranged program for trading company stock, set up when the insider is not aware of material nonpublic information. The filing notes Tucker’s plan was adopted on March 13, 2025, and governed these particular tax-related sales.

How many Addus HomeCare (ADUS) shares does David W. Tucker own after these transactions?

After the reported transactions, Tucker directly owns 10,423 shares of Addus HomeCare common stock. This figure is reported in the Form 4 as his total shares following the most recent open-market sale disclosed in the filing.

What role does David W. Tucker hold at Addus HomeCare (ADUS)?

David W. Tucker serves as Executive Vice President and Chief Strategy Officer at Addus HomeCare. His role is identified in the insider filing, which classifies him as an officer of the company rather than a director or 10% beneficial owner.